A. Kazimi J.'s most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 16 Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on July 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.56 per share. | 01 Jul 2025 | 16 | 5,699,636 (37%) | 0% | 3.6 | 57 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 01 Jul 2025 | 16 | 5,699,716 (37%) | 0% | 3.4 | 54 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.56 per share. | 01 Jul 2025 | 16 | 5,699,700 (37%) | 0% | 3.6 | 57 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.56 per share. | 01 Jul 2025 | 16 | 5,699,684 (37%) | 0% | 3.6 | 57 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 16 | 5,699,668 (37%) | 0% | 3.5 | 56 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.44 per share. | 01 Jul 2025 | 16 | 5,699,652 (37%) | 0% | 3.4 | 55 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.81 per share. | 01 Jul 2025 | 16 | 5,699,620 (37%) | 0% | 3.8 | 61 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.81 per share. | 01 Jul 2025 | 16 | 5,699,604 (37%) | 0% | 3.8 | 61 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.44 per share. | 01 Jul 2025 | 16 | 5,699,588 (37%) | 0% | 3.4 | 55 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.44 per share. | 01 Jul 2025 | 16 | 5,699,572 (37%) | 0% | 3.4 | 55 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 01 Jul 2025 | 16 | 5,699,556 (37%) | 0% | 3.2 | 51 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 01 Jul 2025 | 16 | 5,699,540 (37%) | 0% | 3.2 | 51 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 01 Jul 2025 | 16 | 5,699,524 (37%) | 0% | 3.1 | 49 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 01 Jul 2025 | 16 | 5,699,508 (37%) | 0% | 3.1 | 49 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.25 per share. | 01 Jul 2025 | 16 | 5,699,492 (37%) | 0% | 3.3 | 52 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Jul 2025 | 16 | 5,699,476 (37%) | 0% | 3.3 | 53 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 01 Jul 2025 | 16 | 5,699,460 (37%) | 0% | 3.5 | 56 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.56 per share. | 01 Jul 2025 | 16 | 5,699,444 (37%) | 0% | 3.6 | 57 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.54 per share. | 01 Jul 2025 | 13 | 5,699,768 (37%) | 0% | 3.5 | 46 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.54 per share. | 01 Jul 2025 | 13 | 5,699,755 (37%) | 0% | 3.5 | 46 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Jul 2025 | 13 | 5,699,742 (37%) | 0% | 3.3 | 43 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 01 Jul 2025 | 13 | 5,699,729 (37%) | 0% | 3.5 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 02 Jun 2025 | 16 | 5,699,428 (37%) | 0% | 2.8 | 44 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 02 Jun 2025 | 8 | 5,699,284 (37%) | 0% | 5.8 | 46 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 02 Jun 2025 | 8 | 5,699,292 (37%) | 0% | 5.5 | 44 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.25 per share. | 02 Jun 2025 | 8 | 5,699,396 (37%) | 0% | 3.3 | 26 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 02 Jun 2025 | 8 | 5,699,404 (37%) | 0% | 2.8 | 22 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 02 Jun 2025 | 8 | 5,699,412 (37%) | 0% | 2.6 | 21 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 02 Jun 2025 | 8 | 5,699,300 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 02 Jun 2025 | 8 | 5,699,308 (37%) | 0% | 6 | 48 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 02 Jun 2025 | 8 | 5,699,316 (37%) | 0% | 6 | 48 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 02 Jun 2025 | 8 | 5,699,324 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 02 Jun 2025 | 8 | 5,699,332 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 02 Jun 2025 | 8 | 5,699,340 (37%) | 0% | 5.8 | 46 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 02 Jun 2025 | 8 | 5,699,348 (37%) | 0% | 5.4 | 43 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 02 Jun 2025 | 8 | 5,699,356 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 02 Jun 2025 | 8 | 5,699,364 (37%) | 0% | 5.5 | 44 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 02 Jun 2025 | 8 | 5,699,372 (37%) | 0% | 5.3 | 42 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.62 per share. | 02 Jun 2025 | 8 | 5,699,380 (37%) | 0% | 4.6 | 37 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.88 per share. | 02 Jun 2025 | 8 | 5,699,388 (37%) | 0% | 3.9 | 31 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 02 Jun 2025 | 8 | 5,699,268 (37%) | 0% | 5.3 | 42 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 02 Jun 2025 | 8 | 5,699,276 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 01 May 2025 | 8 | 5,699,100 (37%) | 0% | 4.9 | 39 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 01 May 2025 | 8 | 5,699,260 (37%) | 0% | 4.9 | 39 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 01 May 2025 | 8 | 5,699,252 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 01 May 2025 | 8 | 5,699,244 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 01 May 2025 | 8 | 5,699,236 (37%) | 0% | 5.3 | 42 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.12 per share. | 01 May 2025 | 8 | 5,699,228 (37%) | 0% | 5.1 | 41 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.12 per share. | 01 May 2025 | 8 | 5,699,220 (37%) | 0% | 5.1 | 41 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 01 May 2025 | 8 | 5,699,212 (37%) | 0% | 5 | 40 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 01 May 2025 | 8 | 5,699,204 (37%) | 0% | 5.4 | 43 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 01 May 2025 | 8 | 5,699,196 (37%) | 0% | 4.9 | 39 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 01 May 2025 | 8 | 5,699,188 (37%) | 0% | 5.4 | 43 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 01 May 2025 | 8 | 5,699,180 (37%) | 0% | 5.3 | 42 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 01 May 2025 | 8 | 5,699,172 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.62 per share. | 01 May 2025 | 8 | 5,699,164 (37%) | 0% | 5.6 | 45 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 01 May 2025 | 8 | 5,699,156 (37%) | 0% | 5.3 | 42 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 01 May 2025 | 8 | 5,699,148 (37%) | 0% | 4.8 | 38 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 01 May 2025 | 8 | 5,699,140 (37%) | 0% | 4.5 | 36 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 01 May 2025 | 8 | 5,699,132 (37%) | 0% | 4.8 | 38 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.62 per share. | 01 May 2025 | 8 | 5,699,124 (37%) | 0% | 4.6 | 37 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.62 per share. | 01 May 2025 | 8 | 5,699,116 (37%) | 0% | 4.6 | 37 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 01 May 2025 | 8 | 5,699,108 (37%) | 0% | 4.8 | 38 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Apr 2025 | 10 | 5,698,988 (37%) | 0% | 4 | 40 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 01 Apr 2025 | 10 | 5,698,998 (37%) | 0% | 4.1 | 41 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 01 Apr 2025 | 10 | 5,699,008 (37%) | 0% | 4.2 | 42 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 01 Apr 2025 | 10 | 5,699,018 (37%) | 0% | 4.6 | 46 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.90 per share. | 01 Apr 2025 | 10 | 5,699,068 (37%) | 0% | 4.9 | 49 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 01 Apr 2025 | 10 | 5,699,058 (37%) | 0% | 5.1 | 51 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 01 Apr 2025 | 10 | 5,699,048 (37%) | 0% | 5 | 50 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.70 per share. | 01 Apr 2025 | 10 | 5,699,038 (37%) | 0% | 4.7 | 47 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.80 per share. | 01 Apr 2025 | 10 | 5,699,028 (37%) | 0% | 4.8 | 48 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 01 Apr 2025 | 8 | 5,699,092 (37%) | 0% | 4.8 | 38 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Apr 2025 | 8 | 5,698,978 (37%) | 0% | 4 | 32 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 01 Apr 2025 | 8 | 5,699,084 (37%) | 0% | 4.9 | 39 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.88 per share. | 01 Apr 2025 | 8 | 5,699,076 (37%) | 0% | 4.9 | 39 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 01 Apr 2025 | 8 | 5,698,914 (37%) | 0% | 4.3 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.38 per share. | 01 Apr 2025 | 8 | 5,698,922 (37%) | 0% | 4.4 | 35 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 01 Apr 2025 | 8 | 5,698,930 (37%) | 0% | 4.3 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 01 Apr 2025 | 8 | 5,698,938 (37%) | 0% | 4.3 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 01 Apr 2025 | 8 | 5,698,946 (37%) | 0% | 4.3 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.12 per share. | 01 Apr 2025 | 8 | 5,698,954 (37%) | 0% | 4.1 | 33 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.12 per share. | 01 Apr 2025 | 8 | 5,698,962 (37%) | 0% | 4.1 | 33 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Apr 2025 | 8 | 5,698,970 (37%) | 0% | 4 | 32 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 100,000 | 468,000 | - | - | Options (right to buy) | |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.17 per share. | 17 Mar 2025 | 3,558 | 5,698,738 (37%) | 0% | 5.2 | 18,395 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.80 per share. | 03 Mar 2025 | 10 | 5,698,768 (37%) | 0% | 6.8 | 68 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 03 Mar 2025 | 10 | 5,698,748 (37%) | 0% | 5.5 | 55 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 03 Mar 2025 | 10 | 5,698,758 (37%) | 0% | 5.1 | 51 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.60 per share. | 03 Mar 2025 | 10 | 5,698,778 (37%) | 0% | 6.6 | 66 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.50 per share. | 03 Mar 2025 | 10 | 5,698,788 (37%) | 0% | 6.5 | 65 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.38 per share. | 03 Mar 2025 | 8 | 5,698,866 (37%) | 0% | 4.4 | 35 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 03 Mar 2025 | 8 | 5,698,874 (37%) | 0% | 4.5 | 36 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.38 per share. | 03 Mar 2025 | 8 | 5,698,882 (37%) | 0% | 4.4 | 35 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 03 Mar 2025 | 8 | 5,698,890 (37%) | 0% | 4.3 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 03 Mar 2025 | 8 | 5,698,898 (37%) | 0% | 4.3 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 03 Mar 2025 | 8 | 5,698,906 (37%) | 0% | 4.3 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.86 per share. | 03 Mar 2025 | 7 | 5,698,795 (37%) | 0% | 5.9 | 41 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 03 Mar 2025 | 7 | 5,698,802 (37%) | 0% | 4.9 | 34 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.14 per share. | 03 Mar 2025 | 7 | 5,698,809 (37%) | 0% | 5.1 | 36 | Common Stock |
Cumberland Pharmaceuticals... | A. J. Kazimi | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.43 per share. | 03 Mar 2025 | 7 | 5,698,816 (37%) | 0% | 5.4 | 38 | Common Stock |